BCC tumors have been found to have high rates of TP53 mutations, which lead to a loss of genomic integrity since the TP53 gene encodes the P53 protein, a regulatory protein involved in DNA repair [37,38,39]. The gene discussed is TP53; the disease is skin basal cell carcinoma.